Sponsored by:
Surgery Morbidity and
Mortality Case Conference
Academic Year 2011-2012
Surgery M&M Case Conference
July 27, 2011
7:15am-8:30am
Surgery Theatre-Ground White
Nina Bowens, MD
Target Audience
This program has been designed for Department of Surgery.
Educational Objectives
After completing this activity, participants should be able to:
 Recognize and discuss surgical complications, the associated pathophysiology and the management therefore,
including medico-legal ramifications
 Describe new trend and therapeutic modalities in surgery today
 Participate in eh peer review process for surgery as required by accrediting entities
 Identify alternate methods in which complications can be intervened in order to avoid future problems
Accreditation
The University of Pennsylvania School of Medicine is accredited by the Accreditation Council for Continuing Medical
Education (ACCME) to provide continuing medical education for physicians.
Designation of Credit
The University of Pennsylvania School of Medicine designates this educational activity for a maximum of 1.25 AMA PRA
Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the
activity.
Acknowledgement of Commercial Support*
NONE
For more information, please contact
Laura Mayo
215-662-2016
laura.mayo@uphs.upenn.edu
Check your CME online at www.med.upenn.edu/cme
Disclosure of Relevant Financial Relationships and Unapproved Uses of Products
It is policy at the University of Pennsylvania School of Medicine for individuals who are in a position to control the
content of an educational activity to disclose to the learners all relevant financial relationships that they have with any
commercial interest that provides products or services that may be relevant to the content of this continuing medical
education activity. For this purpose we consider relationships of the person involved in the CME activity to include
financial relationships of a spouse or partner.
The intent of this policy is not to prevent expert faculty with relevant relationship(s) with commercial interest(s) from
involvement in CME, but rather to ensure that Penn CME-certified activities promote quality and safety, are effective in
improving medical practice, are based on valid content, and are independent of control from commercial interests and
free of commercial bias. Peer review of all content was conducted for all faculty presentations whose disclosure
information provided to the Penn Office of CME was found to contain relationships that created a conflict of interest
relative to the topic of their presentation. In addition, all faculty were instructed to provide balanced, scientifically
rigorous and evidence-based presentations.
The staff in the Office of CME at the University of Pennsylvania School of Medicine and the peer reviewer(s) Zalman
Agus, MD, Associate Dean for CME, have disclosed that they have no relevant financial relationships with any
commercial interests related to the content of this educational activity.
The following individuals have disclosed that they have no relevant financial relationships with any commercial interests
related to the content of this educational activity:
FACULTY NAME
Jon Morris, MD
PRESENTER NAME
Nina Bowens, MD
The following individuals have reported the listed relevant financial relationships with commercial interests related to
the content of this educational activity.
FACULTY NAME
Jeffrey Drebin, MD, PhD
NAME OF COMMERCIAL INTEREST
Genentech
Isis Pharma
Glaxo Smith Kline, Inc.
RELATIONSHIP
Royalty
Investor
Consulting Spouse
PRESENTER NAME
Relevant Financial Relationships: Financial relationships are those relationships in which the individual benefits by receiving a salary,
royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership
interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as
employment, management position, independent contractor (including contracted research), consulting, speaking and teaching,
membership on advisory committees or review panels, board membership, and other activities from which remuneration is received
or expected
DISCLOSURE OF UNAPPROVED USES OF PRODUCTS
PRESENTER NAME
PRODUCT
INVESTIGATIONAL AND/OR OFF-LABEL USE